Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  BASF    BAS   DE000BASF111

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

BASF SE : Rothamsted Research Biotech Experiment Reaps 8% More Oil From Rapeseed

share with twitter share with LinkedIn share with facebook
share via e-mail
11/22/2012 | 06:39pm CEST

By Michael Haddon

Rothamsted Research said Thursday it had successfully performed an experiment which accumulated around 8% more oil from rapeseed by using biotechnology to switch off an enzyme responsible for oil breakdown for the duration of seed development.

The agricultural research centre said further work is required to establish the efficacy of the method in the field and to investigate if it could be applied to other oilseed crops or successfully combined with different approaches to boost yields.

"Oilseed rape has become quite a profitable crop in recent years and the scale of cultivation in the U.K. has increased substantially," said Rothamsted Research's Pete Eastmond. "Farmers receive a bonus at market, based on the oil content of their seed, [so] if this technology translates from laboratory to field, we estimate it could be worth an extra 40 million pounds [$64 million] per year to farmers in the U.K. alone," he added.

Rapeseed is the U.K.'s major vegetable oil crop. The country's harvest declined 7% to 2.6 million tons in 2012 due to poor weather during the spring and summer, according to the farm ministry. A yield decrease of 13%, was mitigated by a 7.2% increase in planted area, to 755,000 hectares, after favorable planting conditions in autumn 2011.

Indeed, rapeseed has become extremely profitable for farmers in recent years as prices have been driven by the increasing popularity of rapeseed oil in cooking as its health benefits have become more widely known, it added.

Vegetable oils are obtained from the seeds and fruits of crop plants such as rapeseed, sunflower, soybean or palm and are a major global commodity. World production has surpassed 150 million metric tons a year and is predicted to rise by 50% within 20 years to meet growing demand.

Rothamsted Research said the experiment used RNA interference as a tool and was performed in collaboration with BASF Plant Science, a subsidiary of BASF SE. (BASFY).

Write to Michael Haddon at [email protected] or on Twitter @MichaelHaddonDJ

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BASF
10/18DJBASF : Shuts Down Plant, Withdraws Product After Technical Defect
10/18 BASF : Force Majeure for ecoflex® and ecovio®
10/18 BASF : enters seed business with Bayer portfolio acquisition
10/18 BASF : joins the Forum for Sustainable Palm Oil (FONAP) as supporting member
10/18 SEPAWA 2017 : BASF showcases solutions to meet current market trends
10/18 BASF : acquires significant parts of Bayers crop science business for 5.2bn
10/18 BASF : Monarch butterflies get an RTP sendoff
10/17 BASF : Sustainable Brands Spotlights SB’17 Copenhagen Program
10/17 BASF : signs agreement to acquire significant parts of Bayer's seed and non-sele..
10/17 BASF : to acquire Bayer business lines
More news
News from SeekingAlpha
10/17 Monsanto Ending On A Position Of Strength
10/16 BASF (BASFY) To Acquire Significant Parts Of Bayer's (BAYZF) Seed And Non-Sel..
10/16 Experts say EPA curbs on Monsanto, BASF herbicides will not halt crop harm
10/14 BASF Buys Bayer's Crop Science Assets At A Fair Price
10/13 Monsanto, BASF accept new restraints on dicamba herbicide
Financials (€)
Sales 2017 63 162 M
EBIT 2017 7 606 M
Net income 2017 4 966 M
Debt 2017 14 535 M
Yield 2017 3,49%
P/E ratio 2017 16,56
P/E ratio 2018 15,93
EV / Sales 2017 1,54x
EV / Sales 2018 1,48x
Capitalization 82 911 M
Chart BASF
Duration : Period :
BASF Technical Analysis Chart | BAS | DE000BASF111 | 4-Traders
Technical analysis trends BASF
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 94,7 €
Spread / Average Target 4,9%
EPS Revisions
Kurt W. Bock Chairman-Executive Board
Jürgen Hambrecht Chairman-Supervisory Board
Hans-Ulrich Engel Chief Financial Officer
Martin Brudermüller Chief Technology Officer
Michael Diekmann Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BASF2.22%97 807
ROYAL DSM26.65%15 303
FMC CORP66.30%12 664